One-Time gene infusion aims to fight duchenne muscular dystrophy

NCT ID NCT07673809

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests a single intravenous dose of a gene therapy called GNR-097 in boys aged 4 to 9 with Duchenne muscular dystrophy (DMD). The therapy uses a harmless virus to deliver a shortened version of the dystrophin gene, which is missing or faulty in DMD. The trial aims to see if the treatment is safe and whether it can improve muscle function. Some participants will receive a placebo first and may get the gene therapy later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GNR-097 (a gene therapy using a harmless virus to deliver a shortened dystrophin gene)
What this could lead to
If successful, this could provide a one-time treatment that helps boys with Duchenne muscular dystrophy maintain muscle strength and slow disease progression.
What could go wrong
This is an early-phase trial with only 32 participants, so results may not apply to everyone. There are risks of serious side effects like muscle inflammation, heart inflammation, or blood clotting issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Medical Research Center for Children

    RECRUITING

    Moscow, 119991, Russia

  • Regional Children's Clinical Hospital

    RECRUITING

    Yekaterinburg, 620149, Russia

  • Republican Scientific and Practical Center Mother and Child

    RECRUITING

    Minsk, 220053, Belarus

  • Russian Children's Clinical Hospital

    RECRUITING

    Moscow, 117513, Russia

  • Saint Petersburg State Pediatric Medical University

    RECRUITING

    Saint Petersburg, 194100, Russia

  • Veltischev Research and Clinical Institute for Pediatrics and Pediatric Surgery of the Pirogov Russian National Research Medical University

    RECRUITING

    Moscow, 125412, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.